Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Gensol Engineering IPO and Sudarshan Pharma IPO.
Gensol Engineering IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Sudarshan Pharma IPO is a SME Fixed Price Issue proposed to list at NSE SME.
| Gensol Engineering IPO | Sudarshan Pharma IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Fixed Price Issue |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt Ltd | First Overseas Capital Limited |
| Registrar | Link Intime India Private Ltd | Kfin Technologies Limited |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Gensol Engineering IPO is up to ₹17.93 Cr whereas the issue size of the Sudarshan Pharma IPO is up to ₹24.77 Cr. The final issue price of Gensol Engineering IPO is ₹83.00 per share and of Sudarshan Pharma IPO is ₹72.00 per share.
| Gensol Engineering IPO | Sudarshan Pharma IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹81.00 per share | |
| Issue Price (Upper) | ₹83.00 per share | |
| Issue Price (Final) | ₹83.00 per share | ₹72.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 21,60,000 shares | 34,40,000 shares |
| Issue Size Total (Amount) | up to ₹17.93 Cr | up to ₹24.77 Cr |
Gensol Engineering IPO opens on Sep 30, 2019, while Sudarshan Pharma IPO opens on Jun 12, 2019. The closing date of Gensol Engineering IPO and Sudarshan Pharma IPO is Oct 04, 2019, and Jun 21, 2019, respectively.
| Gensol Engineering IPO | Sudarshan Pharma IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 30, 2019 | Jun 12, 2019 |
| Issue Close | Oct 04, 2019 | Jun 21, 2019 |
| Basis Of Allotment (Tentative) | Oct 10, 2019 | Jun 20, 2019 |
| Initiation of Refunds (Tentative) | Oct 11, 2019 | Jun 21, 2019 |
| Credit of Share (Tentative) | Oct 14, 2019 | Jun 24, 2019 |
| Listing date (Tentative) | Oct 15, 2019 | Jun 25, 2019 |
| Anchor Lockin End date 1 | Nov 09, 2019 | Jul 20, 2019 |
| Anchor Lockin End date 2 | Jan 08, 2020 | Sep 18, 2019 |
Gensol Engineering IPO P/E ratio is , as compared to Sudarshan Pharma IPO P/E ratio of .
| Gensol Engineering IPO | Sudarshan Pharma IPO | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 96% | 89.29% | ||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 70.72% | 65.63% | ||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||
In the Gensol Engineering IPO retail investors (RII) are offered 10,25,600 shares while in Sudarshan Pharma IPO retail investors are offered 10,25,600 shares. Qualified institutional buyers (QIB) are offered in Gensol Engineering IPO and in Sudarshan Pharma IPO.
| Gensol Engineering IPO | Sudarshan Pharma IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 1,08,800 shares | 1,76,000 shares |
| QIB | ||
| NII | 10,25,600 shares | 16,32,000 shares |
| RII | 10,25,600 shares | 16,32,000 shares |
| Employee | ||
| Others | ||
| Total | 20,51,200 shares | 32,64,000 shares |
Gensol Engineering IPO subscribed 1.32x in total, whereas Sudarshan Pharma IPO subscribed 0.47x.
| Gensol Engineering IPO | Sudarshan Pharma IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 2.27x | 0.17x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.37x | 0.77x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.32x | 0.47x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
